Egfr経路のネガティブレギュレータであるD-cblは,ドロソフィラオオゲネシスのドロソセントラルパターニングに必要である
L M Pai1, G Barcelo, T Schüpbach
1Howard Hughes Medical Institute, Department of Molecular Biology, Princeton University, New Jersey 08544, USA.
Cell
|October 29, 2000
まとめ
D-cblの変異は,ドロソフィラのオオゲネシス中に表皮成長因子受容体 (EGFR) 経路の過活性化を引き起こす. これは,EGFR信号伝達の二重制御を強調し,適切な細胞運命を決定するために,リガンド活性化とD-cbl抑制の両方を要求します.
科学分野:
- 発達生物学 発達生物学とは
- 細胞シグナル伝達 細胞信号伝達
- 遺伝学 遺伝学とは
背景:
- ドロソフィラオゲネシス (Drosophila oogenesis) 中のグルケン菌の非対称的な局所化は,表皮成長因子受容体 (EGFR) 経路を誘発する.
- EGFRのシグナル伝達は,背筋の卵泡の細胞運命を特定するために重要です.
研究 の 目的:
- ドロソフィラ・オオゲネシス中のEGFR活性調節におけるD-cblの役割を調査する.
- EGFRシグナリングを制御するメカニズムを理解し,毛皮の細胞運命を正確に決定します.
主な方法:
- ドロソフィラのモザイク型卵泡細胞システムを利用した.
- D-cbl遺伝子の変異を特定し,分析しました.
- EGFRの活性化に対するリガンド依存性の調査.
主要な成果:
- D-cblの突然変異は,EGFR経路の過剰活性化につながる.
- 異常なEGFR活性化は,リガンドの存在に依存しています.
- D-cblはEGFRの活性を否定的に調節する.
結論:
- EGFRの活性を正確に調節するには,局所的リガンド活性化とD-cbl媒介による抑制の両方が必要です.
- D-cblは,Gurkenの局所的活性化を補完して,腹部毛囊細胞におけるEGFRシグナル伝達の欠如を保証する.
- この二重制御メカニズムは,異なる卵泡細胞運命を確立するために不可欠です.
関連する概念動画
Enzyme-linked Receptors
64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Amplifying Signals via Enzymatic Cascade
15.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Transducer Mechanism: G Protein–Coupled Receptors
9.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
9.0K


